Rentschler Biopharma attends BioTalk, Boston, followed by a tour of our state-of-the-art, award-winning manufacturing facility in Milford!

May 21, 2024

Posted by Rentschler Biopharma Inc

Last week, as part of BIOTalk US in Boston, we invited attendees to tour our state-of-the-art, multi-product manufacturing facility in Milford, MA. Tom Roberts, our President Rentschler Biopharma Inc. and General Manager U.S., our Milford leadership team and technical experts welcomed visitors to our award-winning site. 

They were treated to a firsthand experience of our cutting-edge process science laboratories and our three advanced manufacturing lines. A particular standout was the tour through our brand new, top-of-the-line manufacturing line that boasts an impressive 22,000 square feet of manufacturing clean room space and houses four state-of-the-art 2,000 L single-use bioreactors. 

With this new line, we have doubled our global cGMP capacity. Clients benefit from our global integrated service offering and proven expertise in bioprocess development and manufacturing, along the entire biopharmaceutical value chain. Our facility will mainly focus on the commercial production of highly complex molecules for international clients. 

Rentschler Biopharma: reliability you can trust. Learn more about our integrated solutions customized to your needs:


See all Member News